State IA
Clinical Trials in Iowa
Iowa is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Iowa and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 103 actively recruiting studies with Iowa sites out of 103 registered in total. The busiest research areas in Iowa are Breast Cancer, Metastatic Breast Cancer, Diabetes Mellitus, Type 2. Leading sponsors running trials in the state include National Cancer Institute (NCI), University of Iowa, Pfizer. By stage, Iowa trials break down as Phase 1 (17), Phase 2 (28), Phase 3 (37), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Iowa
Breast Cancer (2)Metastatic Breast Cancer (2)Diabetes Mellitus, Type 2 (2)Stroke (2)Stage IV Renal Cell Cancer AJCC v8 (2)Alopecia Areata (2)Myeloma Multiple (1)Untreated, Unresectable, or Metastatic Colorectal Cancer (1)Acute Myeloid Leukemia (1)Acute Lymphoblastic Leukemia (1)Mixed Lineage Acute Leukemia (1)Mixed Phenotype Acute Leukemia (1)
Frequently Asked Questions — Clinical Trials in Iowa
How many clinical trials are currently recruiting in Iowa?
ClinicalMetric currently tracks 103 actively recruiting clinical trials with at least one location in Iowa. The total number of registered studies—including active but not currently enrolling trials—is 103. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Iowa?
Iowa hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Metastatic Breast Cancer, Diabetes Mellitus, Type 2, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Iowa serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Iowa?
To join a clinical trial in Iowa, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Iowa maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Iowa
NCT06424288 Phase 3
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps Peop...
Condition
Heart Failure
Enrollment
6,712 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT06256588 Phase 3
Recruiting
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants Wit...
Condition
Neoplasms, Head and Neck
Enrollment
864 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT07634380 Phase 1
Recruiting
Sitagliptin With Pembro in RCC and Melanoma
Condition
Advanced Renal Cell Carcinoma
Enrollment
64 pts
Location
United States
Sponsor
Fernando Maciel Barbosa
NCT07383441 Phase 3
Recruiting
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Condition
Advanced Clear Cell Renal Cell Carcinoma
Enrollment
718 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT00736749 N/A
Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Gro...
Condition
Hematopoietic Cell Transplantation Recipient
Enrollment
25,000 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT06951594 N/A
Recruiting
Robotic-Assisted Versus Manual Electrode Array Insertion
Condition
Cochlear Implantation
Enrollment
100 pts
Location
United States
Sponsor
Bruce J Gantz
NCT05696613 Phase 3
Recruiting
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Condition
Primary Membranous Nephropathy
Enrollment
148 pts
Location
United States, Canada, India
Sponsor
Cerium Pharmaceuticals, Inc.
NCT07293351 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or...
Condition
Advanced Renal Cell Carcinoma (RCC)
Enrollment
474 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT03072927 N/A
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Condition
Lumbar Spinal Stenosis
Enrollment
8,000 pts
Location
United States
Sponsor
Stryker Instruments
NCT07594483 N/A
Recruiting
Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
Condition
Major Depressive Disorder
Enrollment
20 pts
Location
United States
Sponsor
Motif Neurotech, Inc.
NCT07172880 N/A
Recruiting
Pregnancy 24/7 Offspring Study
Condition
Healthy
Enrollment
800 pts
Location
United States
Sponsor
Kara Whitaker
NCT02122562 Phase 2
Recruiting
Ketamine Alcohol (in Treatment-Resistant Depression)
Condition
Magnetic Resonance Imaging
Enrollment
60 pts
Location
United States
Sponsor
Mark Niciu
NCT07711002 Phase 3
Recruiting
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC ...
Condition
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Enrollment
1,330 pts
Location
United States, Austria, Brazil
Sponsor
AstraZeneca
NCT07224269 EARLY_Phase 1
Recruiting
Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis
Condition
Amyotrophic Lateral Sclerosis
Enrollment
20 pts
Location
United States
Sponsor
University of Iowa
NCT04088071 N/A
Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Condition
Paroxysmal Atrial Fibrillation
Enrollment
20,000 pts
Location
United States, Canada
Sponsor
Heart Rhythm Clinical and Rese
NCT06405607 Phase 2
Recruiting
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
Condition
Alcohol Use Disorder
Enrollment
80 pts
Location
United States
Sponsor
University of Iowa
NCT05917587 EARLY_Phase 1
Recruiting
Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabe...
Condition
Gestational Diabetes
Enrollment
30 pts
Location
United States
Sponsor
Anna Stanhewicz, PhD
NCT06524544 Phase 3
Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hzi...
Condition
Locally Advanced Urothelial Carcinoma
Enrollment
320 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07607145 N/A
Recruiting
Tailor VHA HH Bundle for Acute Mental Health Care
Condition
Hand Hygiene Compliance
Enrollment
4 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
NCT06873945 Phase 3
Recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alop...
Condition
Alopecia Areata
Enrollment
674 pts
Location
United States, Canada, China
Sponsor
Pfizer
NCT06714253 Phase 1, Phase 2
Recruiting
Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1
Condition
Radiation-Induced Xerostomia and Hyposalivation
Enrollment
42 pts
Location
United States
Sponsor
RiboX Therapeutics Ltd.
NCT06638307 Phase 1
Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Condition
Advanced Breast Cancer
Enrollment
240 pts
Location
United States, Spain
Sponsor
Stemline Therapeutics, Inc.
NCT07733765 Phase 3
Recruiting
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for ...
Condition
Alopecia Areata
Enrollment
336 pts
Location
United States, Canada, China
Sponsor
Pfizer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology